The Long and Short
OneAmerica Financial (ONEAM) offers good relative value
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors.
OneAmerica Financial’s (ONEAM) sole index-eligible bonds offer a nice discount to many comparable high-BBB/low-A credits in the life insurance subgroup, likely due to a lack of active coverage on the credit. The issuer is a stable operator with a solid credit profile and high ratings. ONEAM has experienced some limited disruption from Covid-19 over the past few years, but revenues appear to be stabilizing and returning to pre-pandemic levels. Investors can achieve total yields north of 6% by owning the ONEAM 2050s with a split A/BBB rating profile. Bonds also trade closely in-line with those of larger issuer LNC (Baa1/BBB+/BBB+), which experienced significant operating turbulence at the end of 2022.
Exhibit 1. Long-dated Life Insurance Comps – BBB rating or higher
Source: Amherst Pierpont, Bloomberg/TRACE Indications
ONEAM 4.25% 10/15/50 @+225/OLB, G+224, 6.08%, $75.62
Life insurance comps:
Issuer: OneAmerica Financial Partners Inc. (ONEAM)
Private Placement 144A
ONEAM is a mutual life insurance company, the ultimate parent company is American United Mutual Insurance Holding Company. ONEAM’s three core business lines are Individual Life and Financial Services (ILFS), Retirement Services (RS), and Employee Benefits (EB). The first two account for over 90% of all premiums. Within ILFS, ONEAM offers traditional life insurance, asset-based long-term care (LTC), and annuities products. Asset-based LTC does not carry the same stigma associated with more traditional LTC exposure in the industry, as it enables the policy holder to leverage their death benefit in order to pay long-term care costs. Comparable to peers, ONEAM’s mix of business is considered well diversified as it does not appear overly reliant on a single class of products, such as annuities.
The company has experienced some disruption from Covid-19 with stay-at-home protocols and slow job growth modestly impacting sales over the past few years – a trend we expect will continue to improve as more individuals return to their regular places of employment. According to statutory life statistics, fiscal year 2021 total life revenue of $7.58 billion and lagging-twelve-month total revenue of $6.86 billion as of third quarter 2022 are both back above pre-pandemic levels (2019). Most similarly-positioned life insurance operators saw some form of top-line weakness in 2020 and/or early 2021. Corebridge Financial (CRBG: Baa2/BBB+/A-) saw revenue dip from $31.5 billion in 2019 to $27.3 billion in 2020 before recovering in the subsequent two years. Though revenue was flat from 2019 to 2020, Equitable Holdings (EQH: Baa1/BBB+) experienced a significant drop in premiums in 2021, before recovering in the current year.
ONEAM has total statutory life assets of just under $42 billion with total cash and investments of over $25 billion. Total policy reserves are just over $20 billion as of 3Q22.
The company appears well capitalized. Total capital and surplus were $1.87 billion as of third quarter 2022. The total risk-based capital ratio (TAC/ACL RBC %) as of year-end 2021 was 882%. For comparison purposes, the lower-rated but tighter-trading CRBG credit had a statutory life capital ratio of 760% as of year-end 2021, while the similarly-positioned EQH name was roughly in-line with ONEAM at 876%.
The 2050 bonds are the only index-eligible ONEAM debt issue outstanding, and the $400 million represents the largest public debt maturity in the capital structure. The company has $75 million due in 2026 and $200 million due in 2033. There is currently just over $360 million in cash on the balance sheet. Meanwhile, the ultimate parent company and one of ONEAM’s operating subs have arrangements with FHLB to provide up to $3.5 billion against the company’s investment portfolio in the event of a liquidity crisis providing added protection to debtholders.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.